KIT and neoplasm: The inhibition of VEGFR2 and VEGFR3 also contributes to the remission of tumor metastasis through antiangiogenic and antiproliferative mechanisms, while the inhibition of RAF-1, RET, and KIT pathways leads to reduced cell proliferation and increased apoptosis [25].